AU9029298A - Chemical and pharmacological standardization of herbal extracts - Google Patents

Chemical and pharmacological standardization of herbal extracts Download PDF

Info

Publication number
AU9029298A
AU9029298A AU90292/98A AU9029298A AU9029298A AU 9029298 A AU9029298 A AU 9029298A AU 90292/98 A AU90292/98 A AU 90292/98A AU 9029298 A AU9029298 A AU 9029298A AU 9029298 A AU9029298 A AU 9029298A
Authority
AU
Australia
Prior art keywords
extract
test
chemical
pharmacological
plant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU90292/98A
Other languages
English (en)
Inventor
Kam Wai Chiu
Peter K.T. Pang
Jacqueline J. Shan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Afexa Life Sciences Inc
Original Assignee
CV Technologies Inc
CV Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CV Technologies Inc, CV Technology Inc filed Critical CV Technologies Inc
Publication of AU9029298A publication Critical patent/AU9029298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
AU90292/98A 1997-08-28 1998-08-28 Chemical and pharmacological standardization of herbal extracts Abandoned AU9029298A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5609297P 1997-08-28 1997-08-28
US60056092 1997-08-28
PCT/US1998/017344 WO1999009837A1 (en) 1997-08-28 1998-08-28 Chemical and pharmacological standardization of herbal extracts

Publications (1)

Publication Number Publication Date
AU9029298A true AU9029298A (en) 1999-03-16

Family

ID=22002097

Family Applications (1)

Application Number Title Priority Date Filing Date
AU90292/98A Abandoned AU9029298A (en) 1997-08-28 1998-08-28 Chemical and pharmacological standardization of herbal extracts

Country Status (8)

Country Link
US (1) US6156291A (enExample)
EP (1) EP1006802A4 (enExample)
JP (2) JP4520033B2 (enExample)
KR (1) KR20010023208A (enExample)
CN (1) CN1268027A (enExample)
AU (1) AU9029298A (enExample)
CA (1) CA2301860C (enExample)
WO (1) WO1999009837A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432454B1 (en) * 1997-12-12 2002-08-13 C. V. Technologies, Inc. Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
ATE337788T1 (de) * 1998-03-26 2006-09-15 Phytopharm Plc Steroidale saponine zur behandlung der alzheimerischen krankheit
GB9923076D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
CN1630528A (zh) * 1999-08-30 2005-06-22 独立行政法人科学技术振兴机构 含药用人参的脑细胞或神经细胞保护剂
JP2001139483A (ja) * 1999-08-30 2001-05-22 Japan Science & Technology Corp 薬用人蔘からなる脳細胞または神経細胞保護剤
CA2307393A1 (en) 2000-05-01 2001-11-01 The University Of British Columbia Ginsenoside chemotherapy
US6771369B2 (en) * 2002-03-12 2004-08-03 Analytical Spectral Devices, Inc. System and method for pharmacy validation and inspection
US6884627B2 (en) * 2002-04-05 2005-04-26 Advanced Gene Technology, Corp. Method for ascertaining the quality of herbs
US6855343B2 (en) * 2002-05-21 2005-02-15 Advanced Gene Technology, Corp Method to ascertain the quality of herbs
CA2502849A1 (en) * 2002-10-25 2004-05-13 Sloan-Kettering Institute For Cancer Research Screening, quantitation and identification of active ingredients in natural products
US7491753B2 (en) 2003-07-03 2009-02-17 Mallard Creek Polymers, Inc. Antimicrobial and antistatic polymers and methods of using such polymers on various substrates
MX2007000562A (es) * 2004-07-16 2007-03-30 Univ Columbia Compuestos y su preparacion para el tratamiento de la enfermedad de alzheimer al inhibir la produccion de peptidos beta-amiloideos.
TWI285262B (en) * 2005-06-20 2007-08-11 Dev Center Biotechnology Characteristic mass spectrum fingerprinting setting method and rapid identification method of Chinese herb medicine and prescription
US20070048249A1 (en) 2005-08-24 2007-03-01 Purdue Research Foundation Hydrophilized bactericidal polymers
RU2444541C2 (ru) 2006-08-24 2012-03-10 Маллард Крик Полимерс, Инк. Катионный латекс в качестве носителя биоактивных ингредиентов и способы его получения и использования
EP2135074B1 (en) * 2007-03-30 2016-08-31 Sinoveda Canada Inc Pharmaceutical platform technology for the development of natural products
WO2009094177A1 (en) 2008-01-24 2009-07-30 Raptor Therapeutics Inc. Protopanaxadiol-type ginsenoside compositions and uses thereof
CN102014941B (zh) * 2008-02-29 2013-11-06 阿费克萨生命科学公司 人参提取物对固有及适应性免疫应答的激活
US20100278944A1 (en) * 2009-05-04 2010-11-04 Naturex, S.A. Application of american ginseng to enhance neurocognitive function
US9956241B2 (en) 2009-05-04 2018-05-01 Naturex, S.A. Application of American Ginseng to enhance neurocognitive function
KR20110007473A (ko) * 2009-07-16 2011-01-24 씨제이제일제당 (주) 진세노사이드 강화 분획물을 포함하는 혈압 강하용 조성물
JP5563285B2 (ja) * 2009-12-14 2014-07-30 ライオン株式会社 飲食品、医薬品、又は医薬部外品、並びに、プロトパナキサトリオールの安定化方法、及びプロトパナキサジオールの安定化方法
US20110177179A1 (en) * 2010-01-18 2011-07-21 Sinoveda Canada, Inc. Preparation of botanical extracts containing absorbable components using pharmaceutical platform technology
CN105188724A (zh) * 2013-03-14 2015-12-23 张宗超 用于测定草药的活性成分及其产生的来源和催化途径的方法
US20150044306A1 (en) 2013-08-12 2015-02-12 Melvin Mitchell Process for fractionation and extraction of herbal plant material to isolate extractives for pharmaceuticals and nutraceuticals
US20160085941A1 (en) * 2015-03-13 2016-03-24 Jianyi Zhang Method of Discovery of Effective Components in Herbals Based on Evidences by Reversed-directed Analysis
EP3629731A1 (en) 2017-05-27 2020-04-08 Poly Group LLC Dispersible antimicrobial complex and coatings therefrom
HUE068413T2 (hu) 2017-06-16 2024-12-28 Poly Group LLC Polimer, antimikrobiális felületaktív anyag
BE1027552B1 (fr) 2019-09-03 2021-03-30 Botalys Sa Composition du ginseng et son utilisation comme medicament pour le traitement ou la prevention du stress
WO2021043927A1 (en) 2019-09-03 2021-03-11 Botalys Sa Ginseng composition and use thereof as a medicament
BE1027772B1 (fr) 2019-11-21 2021-06-21 Botalys Sa Composition de ginseng pour ameliorer l'etat de la peau et son utilisation pour le traitement d'une maladie dermatologique
WO2021043389A1 (en) 2019-09-03 2021-03-11 Botalys Sa Ginseng composition and use thereof as a medicament for treatment or prevention of an impaired cognition
US10881983B2 (en) * 2019-09-18 2021-01-05 The Winning Combination Method for extraction of ethyl maltol from passion flower

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753397A (ja) * 1993-08-19 1995-02-28 Inahata Koryo Kk 変異原性抑制剤
JPH07126618A (ja) * 1993-11-04 1995-05-16 Jumoku Chushutsu Seibun Riyou Gijutsu Kenkyu Kumiai 抗酸化剤
US5565200A (en) * 1995-04-14 1996-10-15 University Of Southern California Pharmaceutical preparations derived from korean mistletoe
US6039950A (en) * 1995-04-14 2000-03-21 University Of Southern California Pharmaceutical grade saw palmetto
US5547674A (en) * 1995-04-14 1996-08-20 University Of Southern California Pharmaceutical preparations derived from European mistletoe
JPH11503453A (ja) * 1995-04-14 1999-03-26 ユニバーシティー オブ サザン カリフォルニア ヤドリギ抽出物および方法

Also Published As

Publication number Publication date
JP2001513533A (ja) 2001-09-04
EP1006802A1 (en) 2000-06-14
JP2009292844A (ja) 2009-12-17
WO1999009837A1 (en) 1999-03-04
JP5491114B2 (ja) 2014-05-14
EP1006802A4 (en) 2004-01-14
CN1268027A (zh) 2000-09-27
JP4520033B2 (ja) 2010-08-04
US6156291A (en) 2000-12-05
KR20010023208A (ko) 2001-03-26
CA2301860A1 (en) 1999-03-04
CA2301860C (en) 2009-05-26

Similar Documents

Publication Publication Date Title
US6156291A (en) Chemical and pharmacological standardization of herbal extracts
US6083932A (en) Pharmaceutical compositions derived from ginseng and methods of treatment using same
Schellenberg et al. The fixed combination of valerian and hops (Ze91019) acts via a central adenosine mechanism
EP1151292B1 (en) Process for quality control and standardisation of medicinal plant products
CN109596751A (zh) 一种清热养阴活血祛瘀的脉络宁口服液成分检测方法
CN111487347B (zh) 枳术颗粒指纹图谱的检测方法
Yang et al. Interventional effects of Pueraria oral liquid on T2DM rats and metabolomics analysis
Xu et al. Quality evaluation of traditional chinese medicine prescription in naolingsu capsule based on combinative method of fingerprint, quantitative determination, and chemometrics
Chan et al. Quercetin Potentiates the NGF‐Induced Effects in Cultured PC 12 Cells: Identification by HerboChips Showing a Binding with NGF
CN117054549A (zh) 一种基于谱效关系的百合地黄汤质量评价的方法
CN111948330B (zh) 仁术健胃颗粒指纹图谱的检测方法
CN113791152A (zh) 一种hplc法测定痫愈胶囊中多种有效成分含量的方法
Churchill et al. The nootropic properties of ginseng saponin Rb1 are linked to effects on anxiety
CN110297060A (zh) 一种山苦荬药材指纹图谱检测方法及其指纹图谱
CN113009040B (zh) 一种强力枇杷露指纹图谱的检测方法及其指纹图谱
Mădălina-Georgiana et al. Assessing β-sitosterol levels in dietary supplements for benign prostatic hyperplasia: implications for therapeutic efficacy
Liao et al. Metabolite profile changes in different regions of rat brain affected by Ephedra sinica
JP3126162B2 (ja) 神経細胞賦活物質の製法
HK1027946A (en) Chemical and pharmacological standardization of herbal extracts
Shasha et al. Evaluation of Baishao (Paeoniae Radix Alba) and Chishao (Paeoniae Radix Rubra) from different origins based on characteristic spectra of amino acids
CN111474276B (zh) 一种健阳片制剂的质量控制方法
CN114019072B (zh) 一种基于谱效关系的三七质量检测方法
Dubey et al. Pharmacognostical and Pharmaceutical Analysis of Dviruttara Hingvadi Churna–An Ayurvedic Herbal Formulation for Purishaja Udavarta by Charaka Samhita
Zhao et al. Integrated Lipidomics and Network Pharmacology Reveal Mechanism of Memory Impairment Improvement by Yuanzhi San
Chi et al. Integrated evaluation of HPLC fingerprints for the quality control of Ginseng Yang Rong Wan by multi-wavelength fusion fingerprint method

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted